ConductScience.org, home

Paper26630010

Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.

Reshetnyak AV and 9 others. Proc Natl Acad Sci U S A, 2015. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions. Papers, record 26630010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26630010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
3.27
iCite
Revised in PubMed
2024-05-31
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reshetnyak AVAndrey V
2Murray PBPhillip B
3Shi XXiarong
4Mo ESElizabeth S
5Mohanty JJyotidarsini
6Tome FFrancisco
7Bai HHanwen
8Gunel MMurat
9Lax IIrit
10Schlessinger JJoseph

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytokinesMajor topic
Receptor Protein-Tyrosine KinasesMajor topic
Amino Acid Sequence
Anaplastic Lymphoma Kinase
Animals
Cell Line
Cell Line, Tumor
Cell Proliferation
Doxycycline
Enzyme Activation
HEK293 Cells
Heparin
Humans
Immunoblotting
Ligands
Mice
Molecular Sequence Data
NIH 3T3 Cells
Protein Binding
Sequence Homology, Amino Acid

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 GM007223NIGMS NIH HHSUnited StatesT32GM007223PubMed and NIHNIH RePORTER
T32 GM007324NIGMS NIH HHSUnited StatesT32GM007324PubMedNIH RePORTER
T32 HD007149NICHD NIH HHSUnited StatesT32HD007149PubMedNIH RePORTER
S10RR026992-0110NCRR NIH HHSUnited StatesS10RR026992PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in26676577Adopting ALK and LTK.https://conductscience.org/library/papers/26676577

Source PubMed

Download CSV of comments and corrections

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117625570Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.Nature2007https://conductscience.org/library/papers/17625570PubMed
225605972Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK.Sci Signal2015https://conductscience.org/library/papers/25605972PubMed
317487225Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications.Neuropsychopharmacology2008https://conductscience.org/library/papers/17487225PubMed
418923523Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.Nature2008https://conductscience.org/library/papers/18923523PubMed
518990089High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours.Biochem J2008https://conductscience.org/library/papers/18990089PubMed
619200234ALK (Anaplastic Lymphoma Kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction.Eur J Neurosci2009https://conductscience.org/library/papers/19200234PubMed
722079349Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis.Pharmacol Biochem Behav2012https://conductscience.org/library/papers/22079349PubMed
822439933Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.Cancer Cell2012https://conductscience.org/library/papers/22439933PubMed
923201355Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition.Pharmacol Res2013https://conductscience.org/library/papers/23201355PubMed
1025605792limma powers differential expression analyses for RNA-sequencing and microarray studies.Nucleic Acids Res2015https://conductscience.org/library/papers/25605792PubMed
1125950237The Phyre2 web portal for protein modeling, prediction and analysis.Nat Protoc2015https://conductscience.org/library/papers/25950237PubMed
1216458083Characterization of the expression of the ALK receptor tyrosine kinase in mice.Gene Expr Patterns2006https://conductscience.org/library/papers/16458083PubMed
1311114734The protein tyrosine kinase family of the human genome.Oncogene2000https://conductscience.org/library/papers/11114734PubMed
1411357143Oncogenic kinase signalling.Nature2001https://conductscience.org/library/papers/11357143PubMed
1511278720Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.J Biol Chem2001https://conductscience.org/library/papers/11278720PubMed
1611944974Guidelines for human gene nomenclature.Genomics2002https://conductscience.org/library/papers/11944974PubMed
1712122009Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.J Biol Chem2002https://conductscience.org/library/papers/12122009PubMed
1812975309The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.Genome Res2003https://conductscience.org/library/papers/12975309PubMed
1915218241Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.Cytogenet Genome Res2004https://conductscience.org/library/papers/15218241PubMed
2015226403ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.J Cell Sci2004https://conductscience.org/library/papers/15226403PubMed

See all 29 referencesDownload CSV of references

Cited by94

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
42803850ALK ATI in solid tumours: biological evidence, diagnostic challenges, and clinical relevance. a narrative review.Mol Biol Rep2026https://conductscience.org/library/papers/42803850PubMed
41856795Alk-Fam150b (augmentor α) expression in the paraventricular nucleus of the mouse hypothalamus at molecular resolution, and its sensitivity to acute stress.J Neuroendocrinol2026https://conductscience.org/library/papers/41856795PubMed
41798535Anaplastic Lymphoma Kinase (ALK)-Positive Large B-cell Lymphoma in Children: A Case Report and Review of Literature.Cureus2026https://conductscience.org/library/papers/41798535PubMed
41771741Ribosomal Profiling of the Geniculate Ganglion Identifies the Receptor ALK as Critical for the Development and Maintenance of Oral Sensory Neurons.J Neurosci2026https://conductscience.org/library/papers/41771741PubMed
41063186Plasma ALKAL2 levels are associated with coronary atherosclerosis in patients with type 2 diabetes mellitus.Cardiovasc Diabetol2025https://conductscience.org/library/papers/41063186PubMed
40493183Neuronal ALKAL2 and its ALK receptor contribute to the development of colitis-associated colorectal cancer.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40493183PubMed
40382638AlkTango reveals a role for Jeb/Alk signaling in the Drosophila heart.Cell Commun Signal2025https://conductscience.org/library/papers/40382638PubMed
40208865Reanalysis of cryo-EM data reveals ALK-cytokine assemblies with both 2:1 and 2:2 stoichiometries.PLoS Biol2025https://conductscience.org/library/papers/40208865PubMed
40055571ALK in cancer: from function to therapeutic targeting.Nat Rev Cancer2025https://conductscience.org/library/papers/40055571PubMed
39365866MerTK+ macrophages promote melanoma progression and immunotherapy resistance through AhR-ALKAL1 activation.Sci Adv2024https://conductscience.org/library/papers/39365866PubMed
39222358Genome-wide CRISPR/Cas9 library screen identifies C16orf62 as a host dependency factor for porcine deltacoronavirus infection.Emerg Microbes Infect2024https://conductscience.org/library/papers/39222358PubMed
39138146Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39138146PubMed
38927035Lysophosphatidic Acid Stimulates Mitogenic Activity and Signaling in Human Neuroblastoma Cells through a Crosstalk with Anaplastic Lymphoma Kinase.Biomolecules2024https://conductscience.org/library/papers/38927035PubMed
38904987The Alk receptor tyrosine kinase regulates Sparkly, a novel activity regulating neuropeptide precursor in the Drosophila central nervous system.Elife2024https://conductscience.org/library/papers/38904987PubMed
38397899Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions.Biomedicines2024https://conductscience.org/library/papers/38397899PubMed
38339401Anaplastic Lymphoma Kinase (ALK) in Posterior Cranial Fossa Tumors: A Scoping Review of Diagnostic, Prognostic, and Therapeutic Perspectives.Cancers (Basel)2024https://conductscience.org/library/papers/38339401PubMed
38039964ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells.Cancer Cell2023https://conductscience.org/library/papers/38039964PubMed
37892172Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review.Biomolecules2023https://conductscience.org/library/papers/37892172PubMed
37773318ALK fusions in the pan-cancer setting: another tumor-agnostic target?NPJ Precis Oncol2023https://conductscience.org/library/papers/37773318PubMed
37686528IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway.Cancers (Basel)2023https://conductscience.org/library/papers/37686528PubMed

See all 94 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALKAL1389658Swiss-Prot's referenceshttps://conductscience.org/library/genes/389658NCBI Gene
ALKAL2285016Swiss-Prot's referenceshttps://conductscience.org/library/genes/285016NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
LTK4058PubTator's text mininghttps://conductscience.org/library/genes/4058NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26630010

GET https://conductscience.org/api/papers/v1/26630010/references?page=2